Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

5,139JPY
2:00am EDT
Change (% chg)

¥-128 (-2.43%)
Prev Close
¥5,267
Open
¥5,177
Day's High
¥5,179
Day's Low
¥5,123
Volume
2,422,900
Avg. Vol
2,163,135
52-wk High
¥5,527
52-wk Low
¥4,098

Latest Key Developments (Source: Significant Developments)

Tigenix submits day 120 responses to EMA for CX601 marketing authorization
Thursday, 22 Dec 2016 04:03pm EST 

Tigenix NV : Tigenix NV - Tigenix submits day 120 responses to European Medicines Agency for CX601 marketing authorization . Tigenix- expects to receive EMA day 180 list of outstanding issues in Feb 2017, anticipates decision from EMA on CX601 marketing approval during 2017 .Tigenix- if approved, would trigger the payment by Takeda to Tigenix of euro 15 million.  Full Article

Arcturus Therapeutics announces collaboration with Takeda Pharmaceuticals
Tuesday, 6 Dec 2016 12:55pm EST 

Arcturus Therapeutics : Arcturus Therapeutics announces collaboration with Takeda Pharmaceuticals to develop RNA-based therapeutics for the treatment of Nonalcoholic Steatohepatitis (NASH) .Arcturus Therapeutics- financial terms were not disclosed..  Full Article

Ultragenyx Pharma files prospectus supplement with SEC for resale of up to 352,530 shares of co's common stock held by Takeda Pharmaceutical
Friday, 2 Dec 2016 04:30pm EST 

Takeda Pharmaceutical Co Ltd <4502.T> :Ultragenyx Pharma-Filed prospectus supplement with SEC for resale of up to 352,530 shares of co's common stock held by Takeda Pharmaceutical.  Full Article

Valeant talks to sell Salix unit to Takeda for about $10 bln have broken down - CNBC, citing DJ
Wednesday, 30 Nov 2016 09:40am EST 

: Valeant talks to sell Salix unit to Takeda for about $10 bln have broken down - CNBC, citing DJ ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Takeda Pharmaceutical to raise up to T$35 mln via private placement
Thursday, 6 Oct 2016 07:12am EDT 

Takeda Pharmaceutical Co Ltd <4502.T>:Says it to issue up to 3,500,000 shares via private placement and to raise up to totally T$35 million.  Full Article

Takeda Pharmaceutical to expand into sub-Saharan Africa - Nikkei<4502.T>
Thursday, 25 Aug 2016 03:17pm EDT 

Nikkei : Takeda Pharmaceutical will expand into sub-Saharan Africa with operations set to reach full swing in next two-to-three years .  Full Article

Ultragenyx files for resale of upto 374,590 shares of co
Wednesday, 10 Aug 2016 06:05pm EDT 

Ultragenyx Pharmaceutical :Files for resale of upto 374,590 shares of co by Takeda Pharma Co ltd/its pledgees, assignees/successor-in-interest.  Full Article

Seattle Genetics-randomized phase 3 clinical trial with ADCETRIS meets primary endpoint
Monday, 1 Aug 2016 06:59am EDT 

Seattle Genetics Inc : Takeda and Seattle Genetics announce positive data from phase 3 Alcanza clinical trial of ADCETRIS® (Brentuximab Vedotin) for CD30-expressing cutaneous T-Cell Lymphoma . Randomized phase 3 clinical trial with ADCETRIS met primary endpoint . Intend to submit a supplemental biologics license application to FDA in first half of 2017 for approval .Phase 3 trial with ADCETRIS demonstrated highly statistically significant improvement in rate of objective response lasting at least 4 months.  Full Article

Fujifilm to bid for Takeda's research reagents unit - Nikkei
Thursday, 21 Jul 2016 01:18pm EDT 

: Fujifilm Holdings is set to make an offer for a laboratory chemicals unit of Takeda Pharmaceutical - Nikkei . Takeda is expected to put Wako Pure Chemical Industries on the chopping block as early as August - Nikkei .Among those interested in Wako Pure Chemical Business are Britain's Permira and other equity funds, as well as a major U.S. medical supplies Co - Nikkei.  Full Article

Takeda working with Nomura Holdings to sell chemicals unit - Bloomberg
Thursday, 21 Jul 2016 10:45am EDT 

:Takeda working with Nomura Holdings to sell chemicals unit, which could fetch more than $1 billion - Bloomberg, citing sources.  Full Article

More From Around the Web

BRIEF-Takeda Pharmaceutical forms drug development company with two partners - Nikkei

* Takeda pharmaceutical formed 10 billion yen ($87.2 million) drug development company with two partners